PMID: 9418744Jan 1, 1997Paper

New uses for antidepressants: social phobia

The Journal of Clinical Psychiatry
P E Keck, S L McElroy

Abstract

Data from recent epidemiologic surveys of community populations indicate that social phobia is a common psychiatric disorder and is associated with substantial functional impairment in a number of patients. Social phobia is also often comorbid with major depression, substance use disorders, and other anxiety disorders. Fortunately, a variety of antidepressant medications have been reported to alleviate the symptoms of social phobia. Controlled studies have shown substantial efficacy for the monoamine oxidase inhibitors phenelzine, moclobemide, and brofaromine and the serotonin selective reuptake inhibitors fluvoxamine and sertraline. Other serotonin reuptake inhibitors and venlafaxine have shown promise in case reports and open trials.

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Related Papers

The Journal of Clinical Psychiatry
J W Jefferson
The Journal of Clinical Psychiatry
R MarshallM R Liebowitz
International Clinical Psychopharmacology
M H Pollack, R A Gould
The British Journal of Psychiatry : the Journal of Mental Science
F SchneierM R Liebowitz
© 2021 Meta ULC. All rights reserved